Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Can Fite Biopharma Ltd ADR is a biotechnology business based in the US. Can Fite Biopharma Ltd ADR stocks (CANF.US) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $2.32 – an increase of 19.64% over the previous week. Can Fite Biopharma Ltd ADR employs 8 staff and has a trailing 12-month revenue of around $810,000.
National Bank Direct Brokerage
Finder Award
Interactive Brokers
| Latest market close | $2.68 |
|---|---|
| 52-week range | $1.52 - $11.20 |
| 50-day moving average | $2.07 |
| 200-day moving average | $5.53 |
| Wall St. target price | $40.83 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.95 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $2.68 from 2023-06-01
| 1 week (2023-05-26) | 19.64% |
|---|---|
| 1 month (2023-05-03) | 39.58% |
| 3 months (2023-03-03) | -1.11% |
| 6 months (2022-12-02) | 219.05% |
| 1 year (2022-06-03) | 182.11% |
|---|---|
| 2 years (2021-06-03) | 28.85% |
| 3 years (2020-06-03) | 31.37% |
| 5 years (2018-06-01) | 97.06% |
| Revenue TTM | $810,000 |
|---|---|
| Gross profit TTM | $810,000 |
| Return on assets TTM | -42.73% |
| Return on equity TTM | -107.91% |
| Profit margin | 0% |
| Book value | $1.50 |
| Market capitalisation | $9.1 million |
TTM: trailing 12 months
We're not expecting Can Fite Biopharma Ltd ADR to pay a dividend over the next 12 months.
Can Fite Biopharma Ltd ADR's shares were split on a 1:10 basis on 9 January 2023. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Can Fite Biopharma Ltd ADR shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Can Fite Biopharma Ltd ADR shares which in turn could have impacted Can Fite Biopharma Ltd ADR's share price.
Over the last 12 months, Can Fite Biopharma Ltd ADR's shares have ranged in value from as little as $1.52 up to $11.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Can Fite Biopharma Ltd ADR's is 0.8014. This would suggest that Can Fite Biopharma Ltd ADR's shares are less volatile than average (for this exchange).
Can-Fite BioPharma Ltd. , a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase IIb trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. Can-Fite BioPharma Ltd. has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…Compare some of the best bad credit loans in PEI.
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
